ERK5 Signalling and Resistance to ERK1/2 Pathway Therapeutics: The Path Less Travelled? (2022)
Attributed to:
Defining the role of ERK5 kinase and ERK5 transcriptional activities in cell migration and EMT using novel ERK5 inhibitors
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fcell.2022.839997
Publication URI: http://dx.doi.org/10.3389/fcell.2022.839997
Type: Journal Article/Review
Parent Publication: Frontiers in Cell and Developmental Biology